NAD+animalAnimal model2005

Redefining neuroprotective gene therapeutic strategies: Lessons learned from caloric restriction and NAD(+) metabolism.

Journal of Alzheimer's disease : JAD

confidence

Key findings

Review/perspective article predicting neuroprotection via molecular genetic perturbations affecting nuclear NAD+ metabolism; no clinical/biological endpoints reported.

View source on PubMed (PMID 15665413) ↗

Sample size
N/A
Population
Not applicable (review/perspective article)
Dosing
N/A
Duration
N/A
Route
N/A
Blinding
not_reported
Controls
not_reported
Drug class
coenzyme
Full abstract

Herein a case is made for the development of novel cytoprotective approaches based upon molecular mechanisms thought to underlie the caloric restriction phenomenon. This analysis leads to the prediction that molecular genetic perturbations affecting the metabolism of nuclear NAD(+) and metabolites will be neuroprotective.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.